Omeprazole 20mg

DRUG8 trials

Conditions

Bariatric Surgery CandidateCOVID-19Chronic Rhinosinusitis (Diagnosis)EPSGERDGastroesophageal RefluxHelicobacter Pylori InfectionHypochlorhydria

Phase 1

Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis

CompletedNCT03561233

Khon Kaen UniversityGastroesophageal Reflux, Proton Pubm Inhibitor, Systemic Sclerosis

Start: 2013-05-31End: 2018-06-30Updated: 2018-06-21

Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets

CompletedNCT04199624

Indiana UniversityHypochlorhydria

Start: 2021-10-01End: 2023-06-07Updated: 2025-09-22

Phase 2

Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

WithdrawnNCT03291249

Tiziana Life Sciences LTDNAFLD, NASH - Nonalcoholic Steatohepatitis, T2DM (Type 2 Diabetes Mellitus)

Start: 2017-12-01End: 2019-06-01Updated: 2019-09-12

Phase 4

Omeprazole 20 mg in Patients With Laryngopharyngeal reﬂux and Comorbid Chronic Rhinosinusitis

CompletedNCT03086070

Children's Hospital SrebrnjakChronic Rhinosinusitis (Diagnosis), Laryngopharyngeal Reflux

Start: 2010-01-01End: 2010-06-30Updated: 2020-12-30

Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS

CompletedNCT03238534

Aboca Spa Societa' AgricolaEPS, GERD

Start: 2017-09-12End: 2021-09-03Updated: 2022-11-21

Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity

CompletedNCT03378960

Emilio Vargas CastrillónBariatric Surgery Candidate

Start: 2014-10-31End: 2016-02-29Updated: 2019-02-25

A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis

NCT03908619

Changi General HospitalHelicobacter Pylori Infection

Start: 2019-04-16End: 2021-03-31Target: 252Updated: 2020-10-08

Unknown Phase

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

TerminatedNCT04333407

Imperial College LondonCOVID-19

Start: 2020-04-03End: 2021-11-30Updated: 2023-01-18

Related Papers

Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial

The American Journal of Gastroenterology2023-06-1220 citations

COVID-19 and atherosclerosis: looking beyond the acute crisis

Emergency and Critical Care Medicine2022-01-2710 citations

Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial.

2021-12-2028 citations